The evolution of yes by generation👍!! Three more women found dead in suitcases could be linked to Thai teen murder Iran leaves World Cup with "final note": "Fair play is not a slogan printed on ...

Artificial intelligence is expensive to use, many companies discovered. That has led to a new era of saving costs. Credit...Andrea Chronopoulos Supported by By Eli Tan Reporting from San Francisco ...

Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in plain language, emphasizing the impact that economic ...

It’s inevitable that a business will lose a client at some point. It could be your business’s fault or it could be external circumstances that are out of your control. No matter the reason, a client ...

America’s farms are in trouble, and family-owned farms are the hardest hit. According to the latest data, farm bankruptcies in April shot up to their highest level in six years. Former senator Jon ...

Partygoers dance during DJ Jamie Dred's set at the Jaiye Room event at Speakeasy, May 16, 2026 Credit: Oisakhose Aghomo Since the clubs reopened following COVID-19 lockdown, there’s been a quiet ...

Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...

As Eli Lilly looks to hold its lead in the lucrative obesity market, the company’s next-gen prospect, the triple-G drug retatrutide, has met the primary endpoint for weight loss in another pivotal ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins An experimental shot helped participants ...